- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 188 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2024
- 180 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- November 2023
- 143 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- February 2024
- 160 Pages
Global
From €4522EUR$4,969USD£3,877GBP
In the field of clinical diagnostics, latex agglutination test kits represent a rapid, convenient method for detecting the presence of specific antigens or antibodies in a sample, often related to infectious diseases, autoimmune disorders, and other medical conditions. These tests involve the use of latex beads coated with an antigen or antibody. When a sample containing the target substance is added, it binds to the coating, causing the beads to clump, or agglutinate. This agglutination can be visually observed, providing a qualitative or semi-quantitative result.
Enzymes play a crucial role in enhancing these tests. They are sometimes conjugated to the antibodies or antigens on the latex beads, amplifying the agglutination reaction and thereby improving the sensitivity and specificity of the test. Such enzyme-enhanced assays are particularly useful where high accuracy is essential, such as in the diagnosis of certain diseases or the detection of minute antibody titers.
Many companies operate in the market for latex agglutination test kits. Some well-renowned providers include Thermo Fisher Scientific, which offers a wide range of diagnostic solutions; Becton, Dickinson and Company, known for their medical devices and laboratory equipment; Merck KGaA, with a diversified portfolio including life sciences and healthcare; and Abbott, which develops medical devices and healthcare products. These companies, along with others such as Bio-Rad Laboratories and Cardinal Health, contribute to the availability and advancement of latex agglutination test technologies. Show Less Read more